4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02115204
Recruitment Status : Completed
First Posted : April 15, 2014
Last Update Posted : June 19, 2015
AGO Germany
Information provided by (Responsible Party):
West German Study Group

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2005
  Actual Study Completion Date : August 2010
Publications of Results:
Publications automatically indexed to this study by Identifier (NCT Number):